-
1par Takumi Ogawa, Koji Kashima, Yoshikazu Yuki, Mio Mejima, Shiho Kurokawa, Masaharu Kuroda, Atsushi Okazawa, Hiroshi Kiyono, Daisaku Ohta“... cholera toxin B (CTB) subunit, we previously developed MucoRice-CTB, a rice-based vaccine against cholera...”
Publié 2017
Accéder au texte intégral
article -
2
-
3“... and in development of potential treatments of pathological states. Here we investigate the effect of cholera toxin B...”
Accéder au texte intégral
article -
4
-
5“...ABSTRACT Cholera toxin (CT) from Vibrio cholerae is responsible for the majority of the symptoms...”
Accéder au texte intégral
article -
6par Anouk K Gloudemans, Maud Plantinga, Martin Guilliams, Monique A Willart, Arifa Ozir-Fazalalikhan, Alwin van der Ham, Louis Boon, Nicola L Harris, Hamida Hammad, Henk C Hoogsteden, Maria Yazdanbakhsh, Rudi W Hendriks, Bart N Lambrecht, Hermelijn H Smits“... (NO). We hypothesized that the mucosal adjuvant Cholera Toxin subunit B (CTB) could imprint non-mucosal DCs...”
Publié 2013
Accéder au texte intégral
article -
7
-
8
-
9“..., Infect. Immun. 75:3070–3073, 2007), we demonstrated that antibody to cholera toxin (CT) cross-reacted...”
Accéder au texte intégral
article -
10par Pascal Hoffmann, Marion Burmester, Marion Langeheine, Ralph Brehm, Michael T Empl, Bettina Seeger, Gerhard Breves“... may impair physiological functions of the intestines, for instance by cholera toxin or by heat-labile...”
Publié 2021
Accéder au texte intégral
article -
11par Eun Jin Kim, Dokyung Lee, Se Hoon Moon, Chan Hee Lee, Sang Jun Kim, Jae Hyun Lee, Jae Ouk Kim, Manki Song, Bhabatosh Das, John D Clemens, Jean William Pape, G Balakrish Nair, Dong Wook Kim“.... The classical biotype strains of the sixth pandemic, which encode the classical type cholera toxin (CT), have...”
Publié 2014
Accéder au texte intégral
article -
12par Ok S. Shin, Vincent C. Tam, Masato Suzuki, Jennifer M. Ritchie, Roderick T. Bronson, Matthew K. Waldor, John J. Mekalanos“...: cholera toxin, a potent enterotoxin, and toxin coregulated pilus (TCP), an intestinal colonization factor...”
Publié 2011
Accéder au texte intégral
article -
13par Pascal Hoffmann, Nadine Schnepel, Marion Langeheine, Katrin Künnemann, Guntram A Grassl, Ralph Brehm, Bettina Seeger, Gemma Mazzuoli-Weber, Gerhard Breves“.... Furthermore, the organoid-based 2D monolayers were also confronted with cholera toxin derived from Vibrio...”
Publié 2021
Accéder au texte intégral
article -
14“...) for negative control and cholera toxin for positive control. Mice administered KDP exhibited increased...”
Accéder au texte intégral
article -
15“.... cholerae on ISC division. We report that V. cholerae infection and cholera toxin decrease ISC division...”
Accéder au texte intégral
article -
16par Ana A. Weil, Crystal N. Ellis, Meti D. Debela, Taufiqur R. Bhuiyan, Rasheduzzaman Rashu, Daniel L. Bourque, Ashraful I. Khan, Fahima Chowdhury, Regina C. LaRocque, Richelle C. Charles, Edward T. Ryan, Stephen B. Calderwood, Firdausi Qadri, Jason B. Harris“... also compared the effects of active cholera toxin and the inactive cholera toxin B subunit (which...”
Publié 2019
Accéder au texte intégral
article -
17“... suggesting cholera toxin might have an antineoplastic effect. Here the authors perform a nationwide...”
Accéder au texte intégral
article -
18par Oluwaseyi Adekunle, Alexandra Dretler, Robert C Kauffman, Alice Cho, Nadine Rouphael, Jens Wrammert“...) and cholera toxin (CT). Interestingly, the magnitude of the early plasmablast response at day 7 predicted...”
Publié 2021
Accéder au texte intégral
article -
19par Anita Verma, Miriam M. Ngundi, Gregory A. Price, Kazuyo Takeda, James Yu, Drusilla L. Burns“... mutant tethered to the binding subunit of cholera toxin, which efficiently enters cells using the cholera...”
Publié 2018
Accéder au texte intégral
article -
20“... disease characterized by vomiting and diarrhea. These symptoms are primarily caused by cholera toxin (CT...”
Accéder au texte intégral
article